POTENTIAL SERUM PROTEOMIC MARKERS OF BENIGN UTERINE DISEASES

Objective. To detect potential peptide markers in the female serum, which are suited for the diagnosis of benign uterine diseases, by applying the functionalized magnetic beads. Materials and methods. Proteomic profiling of sera from apparently healthy women (n=133; mean age 40 years) and female patients with the verified diagnoses of adenomyosis (n=63; mean age 40 years), uterine myoma (n=48; mean age 42 years), and endometrial hyperplastic processes (n=24; mean age 41 years) by means of MB-WCX magnetic beads with weak cation exchange surface enables the authors to build up classification models with the sensitivity and specificity being close to 100%, by employing a genetic algorithm and a controlled neuronic network. Results. Analysis of the statistical area variation diagrams incorporated into the classification models of mass spectrometric peaks between different groups of samples could reveal 3 peaks for adenomyosis and 3 for uterine myoma. No statistically significant peaks were found for uterine hyperplastic processes. Conclusion. Identification of the proteins specific for adenomyosis and uterine myoma makes it possible to develop innovation methods for the diagnosis, prediction, and treatment of these diseases and to give a better insight into the mechanism of their development, and to substantiate prospects for their treatment.

proteomic profiling, serum, matrix-activated laser desorption/ionization mass spectrometry, biomarkers, adenomyosis, uterine myoma, endometrial hyperplastic processes